Canada markets closed

scPharmaceuticals Inc. (2SX.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
3.0800-0.4400 (-12.50%)
At close: 03:51PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
17,632
13,593
0
0
0
Cost of Revenue
4,991
3,811
0
-
-
Gross Profit
12,641
9,782
0
-
-
Operating Expenses
Research Development
12,419
11,809
15,533
16,039
18,149
Selling General and Administrative
59,920
53,369
20,624
9,784
11,784
Total Operating Expenses
72,339
65,178
36,157
25,823
29,933
Operating Income or Loss
-59,698
-55,396
-36,157
-25,823
-29,933
Interest Expense
8,263
8,123
3,302
2,575
2,587
Total Other Income/Expenses Net
5,587
3,605
1,418
315
-4
Income Before Tax
-57,708
-54,810
-36,838
-28,034
-32,209
Income from Continuing Operations
-57,708
-54,810
-36,838
-28,034
-32,209
Net Income
-57,708
-54,810
-36,838
-28,034
-32,209
Net Income available to common shareholders
-57,708
-54,810
-36,838
-28,034
-32,209
Basic EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Diluted EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Basic Average Shares
36,638
38,514
28,359
27,352
24,569
Diluted Average Shares
36,638
38,514
28,359
27,352
24,569